IDH2 mutations are seemingly specific events in AITL, with a mutation frequency of 20–45% [2,7,8,24,30,58], most of which coexist with TET2 mutations [7,24,30,58]. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.